摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-甲基-2-(3-三氟甲基-苯基)-2,4-二氢-吡唑-3-酮 | 321-05-1

中文名称
5-甲基-2-(3-三氟甲基-苯基)-2,4-二氢-吡唑-3-酮
中文别名
——
英文名称
5-methyl-2-[3-(trifluoromethyl)phenyl]-2,4-dihydropyrazol-3-one
英文别名
1-(3-trifluoromethylphenyl)-3-methyl-2-pyrazolin-5-one;1-[3-(Trifluoromethyl)phenyl]-3-methyl-2-pyrazolin-5-one;3-methyl-1-(3-trifluoromethylphenyl)-3-pyrazolin-5-one;1-(3-Trifluormethylphenyl)-3-methylpyrazolon-5;5-Methyl-2-(3-trifluoromethyl-phenyl)-2,4-dihydro-pyrazol-3-one;5-methyl-2-[3-(trifluoromethyl)phenyl]-4H-pyrazol-3-one
5-甲基-2-(3-三氟甲基-苯基)-2,4-二氢-吡唑-3-酮化学式
CAS
321-05-1
化学式
C11H9F3N2O
mdl
MFCD00443909
分子量
242.2
InChiKey
FLRFRVFQDVMRPE-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.2
  • 重原子数:
    17
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.272
  • 拓扑面积:
    32.7
  • 氢给体数:
    0
  • 氢受体数:
    5

安全信息

  • 海关编码:
    2933199090

SDS

SDS:4b0c4f6cc397da715efbe73bc68953c7
查看

反应信息

  • 作为反应物:
    描述:
    5-甲基-2-(3-三氟甲基-苯基)-2,4-二氢-吡唑-3-酮哌啶 、 sodium hydride 作用下, 以 二甲基亚砜 、 mineral oil 、 正丁醇 为溶剂, 反应 3.5h, 生成 3-methyl-4-((1-(oxiran-2-ylmethyl)-1H-indol-3-yl)methylene)-1-(3-(trifluoromethyl)phenyl)-1H-pyrazol-5(4H)-one
    参考文献:
    名称:
    The discovery of indole derivatives as novel hepatitis C virus inhibitors
    摘要:
    In this study, a library of in-house small molecule was screened using a HCV cell-based assay and a compound (1) containing an N-protected indole scaffold (NINS) was identified as a novel anti-HCV inhibitor. Through structure activity relationship (SAR) study, it was observed that the racemic inhibitor (10m) displayed good anti-HCV activity (EC50 = 1.02 +/- 0.10 mu M) with the excellent selectivity index (SI = 45.56). Interestingly, R-enantiomer ((R)-10m) showed better anti-HCV activity and lower cytotoxicity than S-enantiomer ((S)-10m). (R)-10m gave the best anti-HCV potency (EC50 = 0.72 +/- 0.09 mu M) with the highest selectivity index (SI > 69.44). In addition, the mechanism of action study of NINS derivatives demonstrated that NINS derivatives interfere with the early step (viral entry) of the HCV life cycle. (C) 2016 Elsevier Masson SAS. All rights reserved.
    DOI:
    10.1016/j.ejmech.2016.03.062
  • 作为产物:
    参考文献:
    名称:
    BERTHOLD, R.
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUND
    申请人:Kasai Shizuo
    公开号:US20110251187A1
    公开(公告)日:2011-10-13
    The present invention relates to a compound represented by wherein each symbol is as defined in the specification, a salt thereof and the like.
    本发明涉及一种化合物,其表示为其中每个符号如规范中定义的那样,以及其盐等。
  • Regioselectivity Switch in Palladium‐Catalyzed Allenylic Cycloadditions of Allenic Esters: [4+1] or [4+3] Cycloaddition/Cross‐Coupling
    作者:Long Li、Pengfei Luo、Yuhua Deng、Zhihui Shao
    DOI:10.1002/anie.201901511
    日期:2019.3.26
    The first Pd‐catalyzed asymmetric allenylic [4+1] cycloaddition was successfully developed. Alternatively, tuning the Pd catalyst switched the reactivity toward an unprecedented [4+3] cycloaddition/cross‐coupling. Ligands play a vital role in controlling the reaction pathway, allowing highly selective access to different products from identical substrates. Biological evaluation of the obtained compounds
    首次成功开发了Pd催化的不对称烯丙基[4 + 1]环加成反应。另外,调整Pd催化剂可将反应性转向前所未有的[4 + 3]环加成/交叉偶联。配体在控制反应路径中起着至关重要的作用,可以高度选择性地从相同的底物中获得不同的产物。对获得的化合物的生物学评估导致发现新的抗肿瘤靶标。提出了一种可能的机理,暗示了两个有趣的催化循环,用于与-丁二烯基进行环加成反应。这项研究还证明了烯丙酸酯作为1,4-双亲电子试剂和C 4合成子参与环加成反应的潜力和实用性。
  • Iodine‐Catalyzed Construction of Dihydrooxepines via 3‐Methyl‐5‐Pyrazolones C−H Oxidation/Functionalization of Quinolines Cascade
    作者:Rong Zhang、Jun Wang、Weiwei Jin、Yonghong Zhang、Bin Wang、Yu Xia、Chenjiang Liu
    DOI:10.1002/ejoc.202100541
    日期:2021.7.22
    The iodine-catalyzed catalytic formal [3+3+1] annulation for the construction of a seven-membered O-heteocycle with quinoline is developed. This strategy involves a seven-membered dihydrooxepine with a broad substrate scope through a formal three-component tandem reaction. Further derivation of the target product produced a trioxabicycle scaffold, which formed the basic core of natural products and
    开发了催化的催化形式 [3+3+1] 环化,用于构建带有喹啉的七元 O-杂环。该策略涉及通过正式的三组分串联反应获得具有广泛底物范围的七元二氢氧杂环庚烷。目标产物的进一步衍生得到了三氧杂环骨架,形成了天然产物和药物分子的基本核心,广泛的底物范围显示了一种优雅的合成方法。
  • O‐Acylation of 3‐Methylpyrazol‐5‐ones with Acylisothiocyanates
    作者:Mykhaylo V. Vovk、Andrij V. Bol'but、Pavlo S. Lebed'
    DOI:10.1081/scc-120030702
    日期:2004.12.31
    Abstract 3‐Methylpyrazol‐5‐ones 1 react by the O‐acylation pattern with acylisothiocyanates 2 in the solvent mixture ethanol–dioxane in the presence of the equimolar amount of potassium hydroxide to produce 5‐acyloxy‐3‐methyl‐1H‐pyrazoles 3.
    摘要 在等摩尔量的氢氧化钾存在下,3-甲基吡唑-5-酮 1 通过 O-酰化模式与酰基异硫氰酸酯 2 在溶剂混合物乙醇-二恶烷中反应,生成 5-酰氧基-3-甲基-1H-吡唑 3 .
  • Synthesis of 1,3-Dioxepine-Fused (Tricyclic) Bispyrazoles Involved with Pyrazolone Derivatives and Dichloromethane
    作者:Zongqiang Song、Kai Zhu、Hongqiang Jiang、Hengfa Gong、Zenghui Ye、Fengzhi Zhang
    DOI:10.1021/acs.joc.1c03121
    日期:2022.3.18
    3-dioxepine-fused (tricyclic) bispyrazoles is described. It involves a Cs2CO3-mediated O-alkylation of readily available pyrazolone derivatives with dichloromethane as the methylene source followed by PhI(OAc)2-mediated intramolecular oxidative biheteroaryl coupling under mild conditions. This scalable protocol was applied for the preparation of valuable and novel 1,3-dioxepine-fused (tricyclic) bispyrazoles
    描述了一种简单而新颖的合成新型 1,3-二氧杂环庚烷三环)双吡唑的方法。它涉及以二氯甲烷为亚甲基源的容易获得的吡唑啉酮衍生物的 Cs 2 CO 3介导的O烷基化,然后在温和条件下进行 PhI(OAc) 2介导的分子内氧化二杂芳基偶联。这种可扩展的方案用于制备有价值的新型 1,3-二氧杂环庚烷三环)双吡唑,可在药物或材料化学中找到应用。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫